Starting testosterone replacement therapy is not the end of the diagnostic process. Follow-up evaluates whether symptoms are improving, whether testosterone levels are in an appropriate range, and whether treatment is causing adverse effects. The monitoring plan depends on the original diagnosis, formulation, age, comorbidities, and shared decisions. This article explains common tests without replacing an individualized physician assessment.
Testosterone results depend on timing
A blood testosterone result must be interpreted in relation to the formulation and timing of the last dose. The most informative collection time may differ for injections, gels, and other delivery methods. Clinicians assess the laboratory value alongside symptoms, adherence, and possible adverse effects. A single out-of-range number is not always a reason for an immediate dose change, especially if the specimen was collected at an unexpected point in a dosing cycle.
Complete blood count and hematocrit
Testosterone can stimulate red blood cell production. A complete blood count helps clinicians monitor hemoglobin and hematocrit for erythrocytosis. Elevated hematocrit may require investigation of the dose, formulation, smoking status, hypoxia, or sleep-disordered breathing. The Endocrine Society guideline recommends checking hematocrit before treatment, at approximately 3–6 months after starting therapy, and then annually. A hematocrit above 54% requires prompt clinician assessment and typically withholding testosterone until it returns to a safe level, with evaluation for contributing conditions such as hypoxia or sleep apnea. Patients should not attempt to manage abnormal results by independently altering prescriptions.
Prostate assessment is individualized
Prostate-specific antigen testing and related evaluation are not identical for every patient. Age, personal and family history, baseline findings, and patient preferences affect the discussion. In appropriate patients, clinicians may discuss prostate cancer screening and follow-up before treatment and after initiation. New urinary symptoms, concerning examination findings, or a meaningful PSA change should be reviewed rather than assumed to be an expected consequence of TRT.
Symptoms and conditions that laboratory tests cannot replace
A normal testosterone level does not establish that every symptom is hormone-related. Follow-up may include blood pressure, edema, acne, mood, sexual function, sleep quality, and assessment for obstructive sleep apnea. Clinicians should also revisit fertility goals: exogenous testosterone can suppress sperm production and may not be appropriate when conception is planned. Some patients require additional testing based on their history rather than a standard panel for everyone.
What to bring to a monitoring visit
Bring the exact medication, dose, dosing schedule, last administration time, current supplements, and any new symptoms. Ask when blood should be drawn, how results will be communicated, and which changes should prompt an earlier appointment. Our testosterone replacement therapy evaluation page explains candidacy and treatment options; this article addresses the separate question of follow-up monitoring.
Medical references
- Endocrine Society: Testosterone Therapy Clinical Practice Guideline
- Journal of Clinical Endocrinology & Metabolism: Monitoring Guidance
Educational information only. Individual diagnosis and treatment decisions require evaluation by a qualified clinician.
